NA

From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

Rocca B.
2020-01-01

Abstract

NA
2020
Anticoagulants
Atrial Fibrillation
Clinical Decision-Making
Coronary Artery Disease
Drug Therapy
Combination
Drug Utilization
Dual Anti-Platelet Therapy
Fibrinolytic Agents
Hemorrhage
Humans
Platelet Aggregation Inhibitors
Practice Patterns
Physicians'
Risk Factors
Treatment Outcome
Percutaneous Coronary Intervention
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12572/21344
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
social impact